Osteoarthritis of the Knee, Inflammation, and the Effect of Adalimumab (OKINADA)
Status:
Completed
Trial end date:
2021-03-01
Target enrollment:
Participant gender:
Summary
This is a Canadian randomized, double-blind, placebo-controlled, multicenter study designed
to evaluate the clinical efficacy and safety of adalimumab versus placebo when used to treat
subjects with a diagnosis of osteoarthritis of the knee, and with clinical features of
inflammation, whose pain persists despite receiving maximum tolerated doses of conventional
therapy.